Abstract

Fat flap transplantation is frequently performed in patients suffering from soft tissue defects resulting from disease or trauma. This study explored the feasibility of constructing vascularized fat flaps using rabbit adipose-derived stem cells (rASCs) and collagen scaffolds in a rabbit model. We evaluated rASCs proliferation, paracrine function, adipogenesis, vascularization, and CD54 expression, with or without HIF-1α transfection in vitro and in vivo. We observed that adipogenic differentiation potential was greater in rASCs with high CD54 expression (CD54+rASCs) than in those with low expression (CD54–rASCs), both in vitro and in vivo. HIF-1α overexpression not only augmented this effect, but also enhanced cell proliferation and paracrine function in vitro. We also demonstrated that HIF-1α-transfected CD54+rASCs showed enhanced paracrine function and adipogenic capacity, and that paracrine function increases expression of angiogenesis-related markers. Thus, CD54+rASCs overexpressing HIF-1α enhanced large volume vascularized fat flap regeneration in rabbits, suggesting CD54 may be an ideal candidate marker for ASCs adipogenic differentiation.

Highlights

  • Soft tissue regeneration via adipose tissue engineering is a growing field addressing current clinical demands related to various soft tissue defects [1,2,3,4]

  • This study explored the feasibility of constructing vascularized fat flaps using rabbit adipose-derived stem cells and collagen scaffolds in a rabbit model

  • We demonstrated that HIF-1α-transfected CD54+rabbit adipose-derived stem cells (rASCs) showed enhanced paracrine function and adipogenic capacity, and that paracrine function increases expression of angiogenesis-related markers

Read more

Summary

Introduction

Soft tissue regeneration via adipose tissue engineering is a growing field addressing current clinical demands related to various soft tissue defects [1,2,3,4]. Autologous tissue flaps, fat, or commercially available fillers are commonly used in reconstructive surgeries, for repairing facial tissue defects and tumor resection sites. These strategies achieve clinical success, subsequent volume losses and secondary donor-site deformities challenge long-term efficacies. Emerging tissue engineering strategies represent www.impactjournals.com/oncotarget innovative approaches for many clinical challenges. Such strategies include incorporating seed cells, biodegradable scaffolds, and microenvironments to provide specific inductive signals for tissue regeneration

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call